These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 32670025)

  • 1. Metformin Ameliorates Synaptic Defects in a Mouse Model of AD by Inhibiting Cdk5 Activity.
    Wang Y; Zhao J; Guo FL; Gao X; Xie X; Liu S; Yang X; Yang X; Zhang L; Ye Y; Fan L; Wang J
    Front Cell Neurosci; 2020; 14():170. PubMed ID: 32670025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-diabetes drug pioglitazone ameliorates synaptic defects in AD transgenic mice by inhibiting cyclin-dependent kinase5 activity.
    Chen J; Li S; Sun W; Li J
    PLoS One; 2015; 10(4):e0123864. PubMed ID: 25875370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The regulation of cyclin-dependent kinase 5 activity through the metabolism of p35 or p39 Cdk5 activator.
    Hisanaga S; Saito T
    Neurosignals; 2003; 12(4-5):221-9. PubMed ID: 14673209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p39 Is Responsible for Increasing Cdk5 Activity during Postnatal Neuron Differentiation and Governs Neuronal Network Formation and Epileptic Responses.
    Li W; Allen ME; Rui Y; Ku L; Liu G; Bankston AN; Zheng JQ; Feng Y
    J Neurosci; 2016 Nov; 36(44):11283-11294. PubMed ID: 27807169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of p25/Cdk5 Attenuates Tauopathy in Mouse and iPSC Models of Frontotemporal Dementia.
    Seo J; Kritskiy O; Watson LA; Barker SJ; Dey D; Raja WK; Lin YT; Ko T; Cho S; Penney J; Silva MC; Sheridan SD; Lucente D; Gusella JF; Dickerson BC; Haggarty SJ; Tsai LH
    J Neurosci; 2017 Oct; 37(41):9917-9924. PubMed ID: 28912154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cdk5-p25 as a key element linking amyloid and tau pathologies in Alzheimer's disease: Mechanisms and possible therapeutic interventions.
    Maitra S; Vincent B
    Life Sci; 2022 Nov; 308():120986. PubMed ID: 36152679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TFP5, a Peptide Inhibitor of Aberrant and Hyperactive Cdk5/p25, Attenuates Pathological Phenotypes and Restores Synaptic Function in CK-p25Tg Mice.
    Shukla V; Seo J; Binukumar BK; Amin ND; Reddy P; Grant P; Kuntz S; Kesavapany S; Steiner J; Mishra SK; Tsai LH; Pant HC
    J Alzheimers Dis; 2017; 56(1):335-349. PubMed ID: 28085018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of Cdk5/p25 and tau phosphorylation following chronic brain hypoperfusion in rats involves microRNA-195 down-regulation.
    Sun LH; Ban T; Liu CD; Chen QX; Wang X; Yan ML; Hu XL; Su XL; Bao YN; Sun LL; Zhao LJ; Pei SC; Jiang XM; Zong DK; Ai J
    J Neurochem; 2015 Sep; 134(6):1139-51. PubMed ID: 26118667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of amyloid precursor protein (APP) phosphorylation and processing by p35/Cdk5 and p25/Cdk5.
    Liu F; Su Y; Li B; Zhou Y; Ryder J; Gonzalez-DeWhitt P; May PC; Ni B
    FEBS Lett; 2003 Jul; 547(1-3):193-6. PubMed ID: 12860412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A survey of Cdk5 activator p35 and p25 levels in Alzheimer's disease brains.
    Tseng HC; Zhou Y; Shen Y; Tsai LH
    FEBS Lett; 2002 Jul; 523(1-3):58-62. PubMed ID: 12123804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impairment of hippocampal long-term depression and defective spatial learning and memory in p35 mice.
    Ohshima T; Ogura H; Tomizawa K; Hayashi K; Suzuki H; Saito T; Kamei H; Nishi A; Bibb JA; Hisanaga S; Matsui H; Mikoshiba K
    J Neurochem; 2005 Aug; 94(4):917-25. PubMed ID: 15992381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of aberrant cyclin-dependent kinase 5/p25 activity in experimental traumatic brain injury.
    Yousuf MA; Tan C; Torres-Altoro MI; Lu FM; Plautz E; Zhang S; Takahashi M; Hernandez A; Kernie SG; Plattner F; Bibb JA
    J Neurochem; 2016 Jul; 138(2):317-27. PubMed ID: 26998748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Partial rescue of the p35-/- brain phenotype by low expression of a neuronal-specific enolase p25 transgene.
    Patzke H; Maddineni U; Ayala R; Morabito M; Volker J; Dikkes P; Ahlijanian MK; Tsai LH
    J Neurosci; 2003 Apr; 23(7):2769-78. PubMed ID: 12684463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p35/Cdk5 pathway mediates soluble amyloid-beta peptide-induced tau phosphorylation in vitro.
    Town T; Zolton J; Shaffner R; Schnell B; Crescentini R; Wu Y; Zeng J; DelleDonne A; Obregon D; Tan J; Mullan M
    J Neurosci Res; 2002 Aug; 69(3):362-72. PubMed ID: 12125077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A peptide derived from cyclin-dependent kinase activator (p35) specifically inhibits Cdk5 activity and phosphorylation of tau protein in transfected cells.
    Zheng YL; Li BS; Amin ND; Albers W; Pant HC
    Eur J Biochem; 2002 Sep; 269(18):4427-34. PubMed ID: 12230554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Profiling of p5, a 24 Amino Acid Inhibitory Peptide Derived from the CDK5 Activator, p35 CDKR1 Against 70 Protein Kinases.
    Binukumar BK; Pelech SL; Sutter C; Shukla V; Amin ND; Grant P; Bhaskar M; Skuntz S; Steiner J; Pant HC
    J Alzheimers Dis; 2016 Sep; 54(2):525-33. PubMed ID: 27567857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adeno-associated virus 9-mediated Cdk5 inhibitory peptide reverses pathologic changes and behavioral deficits in the Alzheimer's disease mouse model.
    He Y; Pan S; Xu M; He R; Huang W; Song P; Huang J; Zhang HT; Hu Y
    FASEB J; 2017 Aug; 31(8):3383-3392. PubMed ID: 28420695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physiological and Pathological Roles of Cdk5: Potential Directions for Therapeutic Targeting in Neurodegenerative Disease.
    Allnutt AB; Waters AK; Kesari S; Yenugonda VM
    ACS Chem Neurosci; 2020 May; 11(9):1218-1230. PubMed ID: 32286796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cyclin-dependent kinase 5 activators p35 and p39 interact with the alpha-subunit of Ca2+/calmodulin-dependent protein kinase II and alpha-actinin-1 in a calcium-dependent manner.
    Dhavan R; Greer PL; Morabito MA; Orlando LR; Tsai LH
    J Neurosci; 2002 Sep; 22(18):7879-91. PubMed ID: 12223541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurotoxicity induces cleavage of p35 to p25 by calpain.
    Lee MS; Kwon YT; Li M; Peng J; Friedlander RM; Tsai LH
    Nature; 2000 May; 405(6784):360-4. PubMed ID: 10830966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.